Roth Capital raised the firm’s price target on Amprius Technologies (AMPX) to $22 from $20 and keeps a Buy rating on the shares. The firm cites the company’s reported record Q1 revenue and the negotiated redemption of legacy warrants, noting it would be “buyer on weakness”, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPX:
- Amit Dayal Reiterates Buy Rating on Amprius, Maintains $18 Price Target on Strong Growth and Improving Profitability
- Amprius Technologies Ramps Growth Amid Margin Squeeze
- Amprius Technologies price target raised to $22 from $20 at Roth Capital
- Amprius Technologies falls -29.0%
- Amprius Technologies announces exchange of public warrants for common stock